FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) has engaged two leading clinicians as consultants to assist in the development and testing relating to the Site-Directed Bone Growth program currently being conducted by the company in collaboration with investigators from Yale University Medical School.
